Clincosm LogoSign in Get a demo

Long-term Prognosis in Stroke Patients

Sponsor
Severance Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT03510312
Collaborator
(none)
9,000
Enrollment
1
Location
120
Duration (Months)
75
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

A single-center cohort of patients with acute ischemic stroke and transient ischemic attack who admitted to the Severance hospital of Yonsei university and their long-term outcomes.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This is a single-center cohort of consecutive patients with acute ischemic stroke and transient ischemic attack who admitted to the Severance hospital of Yonsei university in Republic of Korea.

    Stroke recurrence, Cardiovascular event, all cause mortality and cardiovascular mortality were collected through long-term follow up.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    9000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Long-term Prognosis in Stroke Patients
    Study Start Date :
    Dec 1, 2011
    Anticipated Primary Completion Date :
    Dec 1, 2021
    Anticipated Study Completion Date :
    Dec 1, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    Long-term follow up, observational

    This cohort does not involve interventions, just follow up of prognosis of ischemic stroke/transient ischemic attack patients.

    Outcome Measures

    Primary Outcome Measures

    1. Event of Stroke or transient ischemic attack [through study completion, up to 10 years]

      The time of a stroke or transient ischemic attack occurs (through study completion)

    2. Event of cardiovascular disease (include stroke/transient ischemic attack) [through study completion, up to 10 years]

      The time of a cardiovascular disease (stroke/transient ischemic attack) occurs (through study completion)

    3. All cause mortality [through study completion, up to 10 years]

      The time of death from any cause (through study completion)

    4. Cardiovascular cause mortality (include stroke/transient ischemic attack mortality) [through study completion, up to 10 years]

      The time of death from cardiovascular cause (through study completion)

    5. The modified Rankin Scale (mRS) [3 months]

      Measure functional outcome as the form of mRS at 3 months

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All patients with acute ischemic stroke or transient ischemic attack
    Exclusion Criteria:
    • A patient who did not agree with enrollment of this study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ji Hoe Heo Seoul Korea, Republic of

    Sponsors and Collaborators

    • Severance Hospital

    Investigators

    • Study Chair: Ji Hoe Heo, MD, PhD, Yonsei University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ji Hoe Heo, Professor, Severance Hospital
    ClinicalTrials.gov Identifier:
    NCT03510312
    Other Study ID Numbers:
    • 4-2011-0731
    First Posted:
    Apr 27, 2018
    Last Update Posted:
    Mar 24, 2021
    Last Verified:
    Mar 1, 2021
    Additional relevant MeSH terms:
    Stroke

    Study Results

    No Results Posted as of Mar 24, 2021